The Aidaptus ® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and ...

Owen Mumford thinks Aidaptus has advantages over rival auto-injectors. (Kritchanut/iStock/Getty Images Plus/Getty Images) Stevanato has added another drug delivery ...

Stevanato Group has introduced Deora, a new proprietary pen injector platform targeting incretin-based therapies, as well as supporting other originator and biosimilar drug development programs.

Deora simplifies dose administration with a pull-push mechanism: users pull to set the dose and push to inject.